Jeffrey M. Dayno, PRESIDENT, CEO at Harmony Biosciences Holdings, Inc. (HRMY), sold 38,586 shares at $40.13 ($1.5M) on 2025-01-21, disclosed to the SEC on 2025-01-23.
Scheduled sale ($1.5M) by PRESIDENT, CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.13 | 19,293 | $774K | 50.0% |
| 2 | $40.13 | 19,293 | $774K | 50.0% |
| Total | $40.13 avg | 38,586 | $1.5M | 100% |
| Filing → |
| HRMY | SELL | 2022-11-02 | $827K | — | Filing → |
| HRMY | SELL | 2021-10-20 | $1.6M | — | Filing → |
| HRMY | SELL | 2021-10-07 | $72K | — | Filing → |